Literature DB >> 19033658

An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice.

Farah Sheikh1, Anna Raskin, Pao-Hsien Chu, Stephan Lange, Andrea A Domenighetti, Ming Zheng, Xingqun Liang, Tong Zhang, Toshitaka Yajima, Yusu Gu, Nancy D Dalton, Sushil K Mahata, Gerald W Dorn, Joan Heller Brown, Joan Heller-Brown, Kirk L Peterson, Jeffrey H Omens, Andrew D McCulloch, Ju Chen.   

Abstract

The response of cardiomyocytes to biomechanical stress can determine the pathophysiology of hypertrophic cardiac disease, and targeting the pathways regulating these responses is a therapeutic goal. However, little is known about how biomechanical stress is sensed by the cardiomyocyte sarcomere to transduce intracellular hypertrophic signals or how the dysfunction of these pathways may lead to disease. Here, we found that four-and-a-half LIM domains 1 (FHL1) is part of a complex within the cardiomyocyte sarcomere that senses the biomechanical stress-induced responses important for cardiac hypertrophy. Mice lacking Fhl1 displayed a blunted hypertrophic response and a beneficial functional response to pressure overload induced by transverse aortic constriction. A link to the Galphaq (Gq) signaling pathway was also observed, as Fhl1 deficiency prevented the cardiomyopathy observed in Gq transgenic mice. Mechanistic studies demonstrated that FHL1 plays an important role in the mechanism of pathological hypertrophy by sensing biomechanical stress responses via the N2B stretch sensor domain of titin and initiating changes in the titin- and MAPK-mediated responses important for sarcomere extensibility and intracellular signaling. These studies shed light on the physiological regulation of the sarcomere in response to hypertrophic stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19033658      PMCID: PMC2575833          DOI: 10.1172/JCI34472

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  Changes in titin and collagen underlie diastolic stiffness diversity of cardiac muscle.

Authors:  Y Wu; O Cazorla; D Labeit; S Labeit; H Granzier
Journal:  J Mol Cell Cardiol       Date:  2000-12       Impact factor: 5.000

2.  Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes.

Authors:  Nicole H Purcell; Dina Darwis; Orlando F Bueno; Judith M Müller; Roland Schüle; Jeffery D Molkentin
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

Review 3.  Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death.

Authors:  Orlando F Bueno; Jeffery D Molkentin
Journal:  Circ Res       Date:  2002-11-01       Impact factor: 17.367

4.  Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways.

Authors:  H Yasukawa; M Hoshijima; Y Gu; T Nakamura; S Pradervand; T Hanada; Y Hanakawa; A Yoshimura; J Ross; K R Chien
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

5.  The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice.

Authors:  O F Bueno; L J De Windt; K M Tymitz; S A Witt; T R Kimball; R Klevitsky; T E Hewett; S P Jones; D J Lefer; C F Peng; R N Kitsis; J D Molkentin
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

6.  Expression patterns of FHL/SLIM family members suggest important functional roles in skeletal muscle and cardiovascular system.

Authors:  P H Chu; P Ruiz-Lozano; Q Zhou; C Cai; J Chen
Journal:  Mech Dev       Date:  2000-07       Impact factor: 1.882

7.  Molecular dissection of N2B cardiac titin's extensibility.

Authors:  K Trombitás; A Freiburg; T Centner; S Labeit; H Granzier
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

8.  Identification of differentially expressed genes in cardiac hypertrophy by analysis of expressed sequence tags.

Authors:  D M Hwang; A A Dempsey; C Y Lee; C C Liew
Journal:  Genomics       Date:  2000-05-15       Impact factor: 5.736

9.  FHL2 (SLIM3) is not essential for cardiac development and function.

Authors:  P H Chu; W M Bardwell; Y Gu; J Ross; J Chen
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

10.  Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy.

Authors:  Q Zhou; P H Chu; C Huang; C F Cheng; M E Martone; G Knoll; G D Shelton; S Evans; J Chen
Journal:  J Cell Biol       Date:  2001-11-05       Impact factor: 10.539

View more
  123 in total

1.  The contribution of cellular mechanotransduction to cardiomyocyte form and function.

Authors:  Sean P Sheehy; Anna Grosberg; Kevin Kit Parker
Journal:  Biomech Model Mechanobiol       Date:  2012-07-07

2.  A novel mechanism involving four-and-a-half LIM domain protein-1 and extracellular signal-regulated kinase-2 regulates titin phosphorylation and mechanics.

Authors:  Anna Raskin; Stephan Lange; Katherine Banares; Robert C Lyon; Anke Zieseniss; Leonard K Lee; Katrina G Yamazaki; Henk L Granzier; Carol C Gregorio; Andrew D McCulloch; Jeffrey H Omens; Farah Sheikh
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

3.  Single molecule force spectroscopy of the cardiac titin N2B element: effects of the molecular chaperone alphaB-crystallin with disease-causing mutations.

Authors:  Yi Zhu; Julius Bogomolovas; Siegfried Labeit; Henk Granzier
Journal:  J Biol Chem       Date:  2009-03-12       Impact factor: 5.157

Review 4.  Cardiac titin: a multifunctional giant.

Authors:  Martin M LeWinter; Henk Granzier
Journal:  Circulation       Date:  2010-05-18       Impact factor: 29.690

5.  Adenylyl cyclase 6 deletion reduces left ventricular hypertrophy, dilation, dysfunction, and fibrosis in pressure-overloaded female mice.

Authors:  Tong Tang; N Chin Lai; H Kirk Hammond; David M Roth; Yuan Yang; Tracy Guo; Mei Hua Gao
Journal:  J Am Coll Cardiol       Date:  2010-04-06       Impact factor: 24.094

Review 6.  Muscle giants: molecular scaffolds in sarcomerogenesis.

Authors:  Aikaterini Kontrogianni-Konstantopoulos; Maegen A Ackermann; Amber L Bowman; Solomon V Yap; Robert J Bloch
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

7.  The multifunctional Ca(2+)/calmodulin-dependent protein kinase II delta (CaMKIIδ) phosphorylates cardiac titin's spring elements.

Authors:  Carlos G Hidalgo; Charles S Chung; Chandra Saripalli; Mei Methawasin; Kirk R Hutchinson; George Tsaprailis; Siegfried Labeit; Alicia Mattiazzi; Henk L Granzier
Journal:  J Mol Cell Cardiol       Date:  2012-12-05       Impact factor: 5.000

8.  Interference with ERK(Thr188) phosphorylation impairs pathological but not physiological cardiac hypertrophy.

Authors:  Catharina Ruppert; Katharina Deiss; Sebastian Herrmann; Marie Vidal; Mehmet Oezkur; Armin Gorski; Frank Weidemann; Martin J Lohse; Kristina Lorenz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

9.  Dysregulation of FHL1 spliceforms due to an indel mutation produces an Emery-Dreifuss muscular dystrophy plus phenotype.

Authors:  Heather R Tiffin; Zandra A Jenkins; Mary J Gray; Sophia R Cameron-Christie; Jennifer Eaton; Salim Aftimos; David Markie; Stephen P Robertson
Journal:  Neurogenetics       Date:  2013-03-02       Impact factor: 2.660

10.  Deleting Full Length Titin Versus the Titin M-Band Region Leads to Differential Mechanosignaling and Cardiac Phenotypes.

Authors:  Michael H Radke; Christopher Polack; Mei Methawasin; Claudia Fink; Henk L Granzier; Michael Gotthardt
Journal:  Circulation       Date:  2019-04-09       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.